Business Context and Reporting Period
This Form 8-K Current Report was filed by Lantronix, Inc. on June 11, 2012, covering events occurring on June 7 and June 8, 2012. The filing primarily addresses corporate governance changes and regulatory compliance status regarding Nasdaq listing requirements.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial details provided relate to director compensation:
- Cash Compensation: Annual retainer of $26,000 for Board service; $5,000 annual retainer for Chair of the Corporate Governance and Nominating Committee.
- Meeting Fees: $1,000 per in-person meeting and $500 per telephone meeting (Board and Committee).
- Equity Grant: Nonstatutory stock option to purchase 9,895 shares at an exercise price of $1.95 per share.
Material Changes
The filing reports two significant material changes:
- Board Appointment: Paul F. Folino was appointed as a member of the Board of Directors, effective June 7, 2012. He was simultaneously appointed as Chair of the Corporate Governance and Nominating Committee and as a member of the Audit and Compensation Committees.
- Regulatory Compliance: The Company previously received notice of non-compliance with Nasdaq Listing Rule 5605(c)(2)(A) due to the resignation of a director, which left the Audit Committee with fewer than three independent directors. Following Mr. Folino's appointment, the Company received confirmation from Nasdaq on June 8, 2012, that it had regained compliance within the cure period.
Outlook, Risks, and Management Commentary
Management Commentary: The Board concluded that Mr. Folino qualifies as an "independent director" under applicable Nasdaq Listing Rules. The filing notes there are no related party transactions requiring disclosure under Item 404(a) of Regulation S-K.
Risks and Contingencies: The primary risk addressed was the potential delisting or failure to satisfy continued listing standards due to Audit Committee composition. This risk was mitigated by the timely appointment of Mr. Folino.
Unusual Items: None reported beyond the standard director appointment and regulatory cure.
Investor Verification Checklist
- Verify the independence status of Paul F. Folino as defined by Nasdaq Listing Rules.
- Confirm the vesting schedule and expiration terms of the 9,895 stock options granted to Mr. Folino.
- Review the attached Stock Option Award Agreement (Exhibit 99.1) and Indemnification Agreement (Exhibit 99.2) for full legal terms.
- Monitor future filings to ensure the Audit Committee maintains the required number of independent directors.